Sean Christian Schuett Rivrud: Research on Personalizing Thromboprophylaxis Published in JTH and RPTH
Sean Christian Schuett Rivrud, MD/PhD Candidate at the University Medical Center Groningen’s ICU and Department of Hematology, and Medical Student at the University of Groningen, shared a post on LinkedIn:
”This summer I had the opportunity to present the first two chapters of my PhD on personalizing thromboprophylaxis in high-risk patients at the annual conference of the International Society on Thrombosis and Haemostasis (ISTH).
Now I’m very excited that both chapters are now available online in the Journal of Thrombosis and Haemostasis (JTH) and Research and Practice in Thrombosis and Haemostasis.
A big thank you to my incredible collaborators and mentors who made this possible!
Check them out here:
High-dose postpartum thromboprophylaxis in women at high risk of pregnancy-related venous thromboembolism. Read the full article here.
Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT).Read the full article here.”
Title 1: High-dose postpartum thromboprophylaxis in women at high risk of pregnancy-related venous thromboembolism: a single-center prospective cohort study
Title 2: Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT): a model development and validation study
Authors: Sean C.S. Rivrud, Èmese R.H. Heijkoop, Marloes A.G. Holswilder–Olde Scholtenhuis, Karina Meijer
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Dec 17, 2025, 15:24Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
-
Dec 17, 2025, 15:01WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
-
Dec 17, 2025, 14:44Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
-
Dec 17, 2025, 14:29Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID